GSK4771261
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK4771261, covering 2025-08-07 to 2025-08-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease [Phase 1]